News
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...
The UCLA advance opens the door to growing other vascularized organ models, including intestines and colons, providing ...
Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.
Prof. Moran Hausman-Kedem, a pediatric neurologist involved in the research, emphasized the clinical value of the model: “For rare diseases where patient populations are too small for large-scale ...
As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the ...
Toxic tau To mimic Alzheimer’s disease, the team of US-based scientists used mice that had been genetically altered to have a build-up of tau in their brains. They found that a specific enzyme ...
When Kim characterized the mice, he found this G51D mouse model fully recapitulates the progression of Parkinson's disease in a manner that is similar to how it develops in humans.
When Kim characterized the mice, he found this G51D mouse model fully recapitulates the progression of Parkinson’s disease in a manner that is similar to how it develops in humans. The mice begin to ...
Molecule restores cognition and memory in Alzheimer’s disease mouse study - University of California
In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognifitive functions in mice with Alzheimer’s disease symptoms. The compound effectively ...
Scientists in Texas have created the world's first mouse model with a fully functional human immune system. By Inno Flores Updated: Jul 08 2024, 04:08 AM EDT ...
A RIKEN-developed mouse model of an enigmatic lung disease promises to unlock new biological insights and catalyze the development of treatments for millions affected globally 1. Idiopathic pulmonary ...
The search for a good model of late-onset Alzheimer’s disease continues. Researchers led by Adrian Oblak of the Indiana University School of Medicine in Indianapolis and Gareth Howell at the Jackson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results